Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma

Fig. 1

GINA treatment recommendations for patients aged ≥ 5 years, 6–11 years and ≥ 12 years [4]. FEV1, forced expiratory volume in 1 s; GINA, Global Initiative for Asthma; HDM, house dust mite; ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonist; LTRA, leukotriene receptor antagonist; OCS, oral corticosteroids; SABA, short-acting β2-agonist; SLIT, sublingual immunotherapy

Back to article page